Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas

This publication has 31 references indexed in Scilit:

• Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene
  Oncogene, 2004
• Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s Disease
  Clinical Cancer Research, 2004
• The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex
  Nature Cell Biology, 2004
• Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma
  Oncogene, 2003
• Epigenetic change in pituitary tumorigenesis.
  Endocrine-Related Cancer, 2003
• Haploinsufficiency of p18^INK4c Sensitizes Mice to Carcinogen-Induced Tumorigenesis
  Molecular and Cellular Biology, 2003
• Role of E-Cadherin, α-, β-, and γ-Catenins, and p120 (Cell Adhesion Molecules) in Prolactinoma Behavior
  Laboratory Investigation, 2002
• The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
  Molecular and Cellular Biology, 2002
• The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas
  Oncogene, 2001
• Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
  Oncogene, 2001